Alain Claude-Marie Daugan

Tetracyclic derivatives; process of preparation and use

The discovery of tadalafil: A novel and highly selective PDE5 inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1', 2':1,6]pyrido[3,4-b]indole-1,4-dione analogues

The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1: 5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues.

Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use

Use of cGMP-phosphodiesterase inhibitors in methods and compositions to treat impotence

Use of therapeutic benzamide derivatives

Tetracyclic diketopiperazine compounds as pdev inhibitors

Treatment method using a cGMP-Specific PDE inhibitor

Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents

Use of cGMP phosphodiesterase inhibitors in methods to treat female sexual dysfunction